Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.
28.03.2022Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.
Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.
28.03.2022Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.
ÎÞÓǶÌÊÓƵ CEO Dr Mark Kotter interviewed by Fiona Mischel on the Built with Biology Podcast.
25.03.2022They ask about reprogramming cells and how the company is aiming to develop cell therapies.
17.03.2022The article offers 6 tips for successful pharma startups.
01.03.2022This case study delves into the company story, technology and vision.
16.02.2022The list looks at how companies are performing and what they are working on.
10.02.2022Technology Networks cover the development, benefits and applications of ioSkeletal Myocytes.
03.02.2022Founder and CEO Dr Mark Kotter joined the experts who have given their thoughts on what is to come for the health sector in 2022.
31.01.2022Wired spoke to ÎÞÓǶÌÊÓƵ's CEO and CMO about reprogramming cells for therapies.
21.12.2021